» Articles » PMID: 16118219

SphK1 and SphK2, Sphingosine Kinase Isoenzymes with Opposing Functions in Sphingolipid Metabolism

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2005 Aug 25
PMID 16118219
Citations 271
Authors
Affiliations
Soon will be listed here.
Abstract

The potent sphingolipid metabolite sphingosine 1-phosphate is produced by phosphorylation of sphingosine catalyzed by sphingosine kinase (SphK) types 1 and 2. In contrast to pro-survival SphK1, the putative BH3-only protein SphK2 inhibits cell growth and enhances apoptosis. Here we show that SphK2 catalytic activity also contributes to its ability to induce apoptosis. Overexpressed SphK2 also increased cytosolic free calcium induced by serum starvation. Transfer of calcium to mitochondria was required for SphK2-induced apoptosis, as cell death and cytochrome c release was abrogated by inhibition of the mitochondrial Ca(2+) transporter. Serum starvation increased the proportion of SphK2 in the endoplasmic reticulum and targeting SphK1 to the endoplasmic reticulum converted it from anti-apoptotic to pro-apoptotic. Overexpression of SphK2 increased incorporation of [(3)H]palmitate, a substrate for both serine palmitoyltransferase and ceramide synthase, into C16-ceramide, whereas SphK1 decreased it. Electrospray ionizationmass spectrometry/mass spectrometry also revealed an opposite effect on ceramide mass levels. Importantly, specific down-regulation of SphK2 reduced conversion of sphingosine to ceramide in the recycling pathway and conversely, down-regulation of SphK1 increased it. Our results demonstrate that SphK1 and SphK2 have opposing roles in the regulation of ceramide biosynthesis and suggest that the location of sphingosine 1-phosphate production dictates its functions.

Citing Articles

Sphingosine-1-Phosphate Metabolic Pathway in Cancer: Implications for Therapeutic Targets.

Rufail M, Bassi R, Giussani P Int J Mol Sci. 2025; 26(3).

PMID: 39940821 PMC: 11817292. DOI: 10.3390/ijms26031056.


Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot study.

Alarfaj S, El-Haggar S, Hegazy S, Maher M, Bahgat M, Elmasry T Front Med (Lausanne). 2025; 11:1490178.

PMID: 39911672 PMC: 11794804. DOI: 10.3389/fmed.2024.1490178.


Sphingosine kinase 1 inhibition aggravates vascular smooth muscle cell calcification.

Razazian M, Bahiraii S, Jannat I, Tiffner A, Beilhack G, Levkau B Pflugers Arch. 2025; .

PMID: 39899071 DOI: 10.1007/s00424-025-03068-6.


Evaluation of the effects of short-term PM exposure on triglyceride-glucose metrics in a population in eastern China.

Guo Z, Yang C, Zhang Q, Shi X, Li X, Zhang Q BMC Cardiovasc Disord. 2025; 25(1):44.

PMID: 39849355 PMC: 11755822. DOI: 10.1186/s12872-025-04489-y.


Multiple sphingolipid-metabolizing enzymes modulate influenza virus replication.

McKenna S, Jung K, Wolf J, Seo Y, Hahm B Virology. 2025; 603:110367.

PMID: 39754863 PMC: 11793951. DOI: 10.1016/j.virol.2024.110367.